Molecular IDDM epidemiology: International studies

Janice S. Dorman, Bridget McCarthy, Erin McCanlies, M. Kaye Kramer, Ronald J. Vergona, Roslyn Stone, Ann R. Steenkiste, Mirjana Kocova, Massimo Trucco, O. Ramos, M. Z. Bao, E. Carrasco, M. Garcia De Los Rios, G. Lopez, J. Tuomilehto, F. Tuomilehto-Wolf, G. Vidgren, E. Bosi, V. Lampasona, G. BrunoA. Pagano, G. Pagano, N. Mutsuura, N. Tajima, K. Ko, Y. Park, C. Gorodezky, C. Robles-Valdes, R. Elliott, N. Beckman, S. Seclen, O. Nunez, M. I. Rojas, C. Torres, M. Serrano Rios, M. Calvillan, M. Gutierrez-Lopez, M. T Martinez Larrad, F. Perez-Bravo

Research output: Contribution to journalArticle

Abstract

The WHO DiaMond Molecular Epidemiology Sub-Project is testing the hypothesis that the geographic differences in IDDM incidence reflect population variation in the frequency of IDDM susceptibility genes (i.e., DQA1 and DQB1 alleles with sequences coding for arginine (R) in position 52 of the DQ α-chain, and an amino acid other than aspartic acid (ND) in position 57 of the DQ β-chain, respectively) using a standardized case-control design. Data from twelve populations which have completed (or have nearly completed) recruitment and HLA molecular analyses are presented. There was an approximate 2-fold increase in the frequencies of DQA1*0301, DQB1*0201 and DQB1*0302 among IDDM cases compared to non-diabetic controls in most populations. Interestingly, DQA1*0301 was more common in low versus moderate-high incidence countries. DQB1*0201 and DQB1*0302 were more prevalent in the moderate-high incidence areas. DQA1*R and DQB1*ND were both consistent markers of IDDM risk, with stronger associations in moderate-high versus low incidence areas. In general, individuals homozygous for both DQA1*R and DQB1*ND had the highest genotype-specific IDDM incidence rates, which approximated risk estimates for first degree relatives in several countries. These data revealed considerable variation in the frequencies of DQB1 and DQA1 alleles across countries, which likely contribute to the global patterns of IDDM incidence.

Original languageEnglish
JournalDiabetes Research and Clinical Practice
Volume34
Issue numberSUPPL.
DOIs
Publication statusPublished - Oct 1996

Fingerprint

Molecular Epidemiology
Type 1 Diabetes Mellitus
Incidence
Alleles
Population
Diamond
Aspartic Acid
Arginine
Genotype
Amino Acids
Genes

Keywords

  • genetics
  • HLA-DQ
  • incidence
  • insulin-dependent diabetes mellitus (IDDM)
  • molecular epidemiology

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Dorman, J. S., McCarthy, B., McCanlies, E., Kramer, M. K., Vergona, R. J., Stone, R., ... Perez-Bravo, F. (1996). Molecular IDDM epidemiology: International studies. Diabetes Research and Clinical Practice, 34(SUPPL.). https://doi.org/10.1016/S0168-8227(96)90017-0

Molecular IDDM epidemiology : International studies. / Dorman, Janice S.; McCarthy, Bridget; McCanlies, Erin; Kramer, M. Kaye; Vergona, Ronald J.; Stone, Roslyn; Steenkiste, Ann R.; Kocova, Mirjana; Trucco, Massimo; Ramos, O.; Bao, M. Z.; Carrasco, E.; Garcia De Los Rios, M.; Lopez, G.; Tuomilehto, J.; Tuomilehto-Wolf, F.; Vidgren, G.; Bosi, E.; Lampasona, V.; Bruno, G.; Pagano, A.; Pagano, G.; Mutsuura, N.; Tajima, N.; Ko, K.; Park, Y.; Gorodezky, C.; Robles-Valdes, C.; Elliott, R.; Beckman, N.; Seclen, S.; Nunez, O.; Rojas, M. I.; Torres, C.; Serrano Rios, M.; Calvillan, M.; Gutierrez-Lopez, M.; Larrad, M. T Martinez; Perez-Bravo, F.

In: Diabetes Research and Clinical Practice, Vol. 34, No. SUPPL., 10.1996.

Research output: Contribution to journalArticle

Dorman, JS, McCarthy, B, McCanlies, E, Kramer, MK, Vergona, RJ, Stone, R, Steenkiste, AR, Kocova, M, Trucco, M, Ramos, O, Bao, MZ, Carrasco, E, Garcia De Los Rios, M, Lopez, G, Tuomilehto, J, Tuomilehto-Wolf, F, Vidgren, G, Bosi, E, Lampasona, V, Bruno, G, Pagano, A, Pagano, G, Mutsuura, N, Tajima, N, Ko, K, Park, Y, Gorodezky, C, Robles-Valdes, C, Elliott, R, Beckman, N, Seclen, S, Nunez, O, Rojas, MI, Torres, C, Serrano Rios, M, Calvillan, M, Gutierrez-Lopez, M, Larrad, MTM & Perez-Bravo, F 1996, 'Molecular IDDM epidemiology: International studies', Diabetes Research and Clinical Practice, vol. 34, no. SUPPL.. https://doi.org/10.1016/S0168-8227(96)90017-0
Dorman JS, McCarthy B, McCanlies E, Kramer MK, Vergona RJ, Stone R et al. Molecular IDDM epidemiology: International studies. Diabetes Research and Clinical Practice. 1996 Oct;34(SUPPL.). https://doi.org/10.1016/S0168-8227(96)90017-0
Dorman, Janice S. ; McCarthy, Bridget ; McCanlies, Erin ; Kramer, M. Kaye ; Vergona, Ronald J. ; Stone, Roslyn ; Steenkiste, Ann R. ; Kocova, Mirjana ; Trucco, Massimo ; Ramos, O. ; Bao, M. Z. ; Carrasco, E. ; Garcia De Los Rios, M. ; Lopez, G. ; Tuomilehto, J. ; Tuomilehto-Wolf, F. ; Vidgren, G. ; Bosi, E. ; Lampasona, V. ; Bruno, G. ; Pagano, A. ; Pagano, G. ; Mutsuura, N. ; Tajima, N. ; Ko, K. ; Park, Y. ; Gorodezky, C. ; Robles-Valdes, C. ; Elliott, R. ; Beckman, N. ; Seclen, S. ; Nunez, O. ; Rojas, M. I. ; Torres, C. ; Serrano Rios, M. ; Calvillan, M. ; Gutierrez-Lopez, M. ; Larrad, M. T Martinez ; Perez-Bravo, F. / Molecular IDDM epidemiology : International studies. In: Diabetes Research and Clinical Practice. 1996 ; Vol. 34, No. SUPPL.
@article{068bc1e55fb64eab8df625d2c43eda26,
title = "Molecular IDDM epidemiology: International studies",
abstract = "The WHO DiaMond Molecular Epidemiology Sub-Project is testing the hypothesis that the geographic differences in IDDM incidence reflect population variation in the frequency of IDDM susceptibility genes (i.e., DQA1 and DQB1 alleles with sequences coding for arginine (R) in position 52 of the DQ α-chain, and an amino acid other than aspartic acid (ND) in position 57 of the DQ β-chain, respectively) using a standardized case-control design. Data from twelve populations which have completed (or have nearly completed) recruitment and HLA molecular analyses are presented. There was an approximate 2-fold increase in the frequencies of DQA1*0301, DQB1*0201 and DQB1*0302 among IDDM cases compared to non-diabetic controls in most populations. Interestingly, DQA1*0301 was more common in low versus moderate-high incidence countries. DQB1*0201 and DQB1*0302 were more prevalent in the moderate-high incidence areas. DQA1*R and DQB1*ND were both consistent markers of IDDM risk, with stronger associations in moderate-high versus low incidence areas. In general, individuals homozygous for both DQA1*R and DQB1*ND had the highest genotype-specific IDDM incidence rates, which approximated risk estimates for first degree relatives in several countries. These data revealed considerable variation in the frequencies of DQB1 and DQA1 alleles across countries, which likely contribute to the global patterns of IDDM incidence.",
keywords = "genetics, HLA-DQ, incidence, insulin-dependent diabetes mellitus (IDDM), molecular epidemiology",
author = "Dorman, {Janice S.} and Bridget McCarthy and Erin McCanlies and Kramer, {M. Kaye} and Vergona, {Ronald J.} and Roslyn Stone and Steenkiste, {Ann R.} and Mirjana Kocova and Massimo Trucco and O. Ramos and Bao, {M. Z.} and E. Carrasco and {Garcia De Los Rios}, M. and G. Lopez and J. Tuomilehto and F. Tuomilehto-Wolf and G. Vidgren and E. Bosi and V. Lampasona and G. Bruno and A. Pagano and G. Pagano and N. Mutsuura and N. Tajima and K. Ko and Y. Park and C. Gorodezky and C. Robles-Valdes and R. Elliott and N. Beckman and S. Seclen and O. Nunez and Rojas, {M. I.} and C. Torres and {Serrano Rios}, M. and M. Calvillan and M. Gutierrez-Lopez and Larrad, {M. T Martinez} and F. Perez-Bravo",
year = "1996",
month = "10",
doi = "10.1016/S0168-8227(96)90017-0",
language = "English",
volume = "34",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "SUPPL.",

}

TY - JOUR

T1 - Molecular IDDM epidemiology

T2 - International studies

AU - Dorman, Janice S.

AU - McCarthy, Bridget

AU - McCanlies, Erin

AU - Kramer, M. Kaye

AU - Vergona, Ronald J.

AU - Stone, Roslyn

AU - Steenkiste, Ann R.

AU - Kocova, Mirjana

AU - Trucco, Massimo

AU - Ramos, O.

AU - Bao, M. Z.

AU - Carrasco, E.

AU - Garcia De Los Rios, M.

AU - Lopez, G.

AU - Tuomilehto, J.

AU - Tuomilehto-Wolf, F.

AU - Vidgren, G.

AU - Bosi, E.

AU - Lampasona, V.

AU - Bruno, G.

AU - Pagano, A.

AU - Pagano, G.

AU - Mutsuura, N.

AU - Tajima, N.

AU - Ko, K.

AU - Park, Y.

AU - Gorodezky, C.

AU - Robles-Valdes, C.

AU - Elliott, R.

AU - Beckman, N.

AU - Seclen, S.

AU - Nunez, O.

AU - Rojas, M. I.

AU - Torres, C.

AU - Serrano Rios, M.

AU - Calvillan, M.

AU - Gutierrez-Lopez, M.

AU - Larrad, M. T Martinez

AU - Perez-Bravo, F.

PY - 1996/10

Y1 - 1996/10

N2 - The WHO DiaMond Molecular Epidemiology Sub-Project is testing the hypothesis that the geographic differences in IDDM incidence reflect population variation in the frequency of IDDM susceptibility genes (i.e., DQA1 and DQB1 alleles with sequences coding for arginine (R) in position 52 of the DQ α-chain, and an amino acid other than aspartic acid (ND) in position 57 of the DQ β-chain, respectively) using a standardized case-control design. Data from twelve populations which have completed (or have nearly completed) recruitment and HLA molecular analyses are presented. There was an approximate 2-fold increase in the frequencies of DQA1*0301, DQB1*0201 and DQB1*0302 among IDDM cases compared to non-diabetic controls in most populations. Interestingly, DQA1*0301 was more common in low versus moderate-high incidence countries. DQB1*0201 and DQB1*0302 were more prevalent in the moderate-high incidence areas. DQA1*R and DQB1*ND were both consistent markers of IDDM risk, with stronger associations in moderate-high versus low incidence areas. In general, individuals homozygous for both DQA1*R and DQB1*ND had the highest genotype-specific IDDM incidence rates, which approximated risk estimates for first degree relatives in several countries. These data revealed considerable variation in the frequencies of DQB1 and DQA1 alleles across countries, which likely contribute to the global patterns of IDDM incidence.

AB - The WHO DiaMond Molecular Epidemiology Sub-Project is testing the hypothesis that the geographic differences in IDDM incidence reflect population variation in the frequency of IDDM susceptibility genes (i.e., DQA1 and DQB1 alleles with sequences coding for arginine (R) in position 52 of the DQ α-chain, and an amino acid other than aspartic acid (ND) in position 57 of the DQ β-chain, respectively) using a standardized case-control design. Data from twelve populations which have completed (or have nearly completed) recruitment and HLA molecular analyses are presented. There was an approximate 2-fold increase in the frequencies of DQA1*0301, DQB1*0201 and DQB1*0302 among IDDM cases compared to non-diabetic controls in most populations. Interestingly, DQA1*0301 was more common in low versus moderate-high incidence countries. DQB1*0201 and DQB1*0302 were more prevalent in the moderate-high incidence areas. DQA1*R and DQB1*ND were both consistent markers of IDDM risk, with stronger associations in moderate-high versus low incidence areas. In general, individuals homozygous for both DQA1*R and DQB1*ND had the highest genotype-specific IDDM incidence rates, which approximated risk estimates for first degree relatives in several countries. These data revealed considerable variation in the frequencies of DQB1 and DQA1 alleles across countries, which likely contribute to the global patterns of IDDM incidence.

KW - genetics

KW - HLA-DQ

KW - incidence

KW - insulin-dependent diabetes mellitus (IDDM)

KW - molecular epidemiology

UR - http://www.scopus.com/inward/record.url?scp=0030483432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030483432&partnerID=8YFLogxK

U2 - 10.1016/S0168-8227(96)90017-0

DO - 10.1016/S0168-8227(96)90017-0

M3 - Article

C2 - 9015679

AN - SCOPUS:0030483432

VL - 34

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - SUPPL.

ER -